PT Kimia Farma (Persero) Tbk - D3, S1, S2 PMMB Internship Program Kimia Farma July 2019

Advertisements

PT Kimia Farma (Persero) Tbk / kimiafarma.co.id

PT Kimia Farma (Persero) Tbk - Kimia Farma is a well-established public-listed company in Indonesia that deals with integrated pharmaceutical industry. Kimia Farma has its business activities focused in integrated pharmaceutical industry. Its business include manufacturing, pharmaceutical trade and distribution, retail pharmacy, health clinic, laboratories and optical clinics. Domiciled in Jakarta, Kimia Farma now has 7 production facilities; Plant Jakarta, Plant Bandung, Plant Semarang, Plant Watudakon, Plant Garam Farmasi, Plant Medan, and lant Rapid Test. Kimia Farma also supported by 1 research and development office at Bandung and 1 central logistic unit Jakarta. Kimia Farma also supported 6 directly-owned subsidiaries and affiliated companies, namely PT Kimia Farma Trading & Distribution, PT Kimia Farma Apotek, PT Sinkona Indonesia Lestari, PT Kimia Farma Diagnostik, PT Kimia Farma Sungwun Pharmacopia and PT Asuransi InHealth Indonesia. As of the end of September 2018, Kimia Farma has 1,135 pharmacies, 530 health clinics, 55 clinical laboratories, and 10 optics throughout Indonesia.

PT Kimia Farma (Persero) Tbk  is a state-owned company which is majority owned by the Government of Indonesia. Kimia Farma is listed on the Indonesia Stock Exchange (IDX) under reference code KAEF. At present, Kimia Farma is 90.025% owned by the Government of Indonesia which represented by the Minister of State-Owned Enterprises (SOE). Other 0.127% by management/employee and 9.848% by public.

According to information found in PT Kimia Farma (Persero) Tbk 2018 Third Quarter Report as quoted by JobsCDC.com, Kimia Farma is running well in the third quarter of 2018 (3Q18, ended in 30 September 2018). Kimia Farma booked total net revenue of Rp5.31 trillion (unaudited) as at the end of September 2018. This reflected an 23.37% increase from Rp4.30 trillion (unaudited)  in the same period on 2017. Kima Farma's total profit of Rp483.29 billion in the third quarter of 2018 or 45.31% growth YOY as compared with Rp332.60 billion in the third quarter of 2017.

To support the business expansion and its organic growth, PT Kimia Farma (Persero) Tbk invites qualified candidates to fulfill the position as follows
 
Program Magang Mahasiswa Bersertifikat (PMMB)

Requirements

• Still registered as an active student of Diploma (D3) Degree, Undergraduate Program (S1) or Master Program (S2).
• Universities (PTN/PTS) must be registered in FHCI.
• Have professional practice credit/SKS (for certain faculties / study programs).
• Committed an internship within 6 months.

For further information, please refer official source from PT Kimia Farma (Persero) Tbk on following link below. If you match the profile and are interested to join internship program, please apply in confidence by filling online application form at  bit.ly/internshipkaef. All applications are appreciated and will be treated confidentially. Only qualified, short-listed applicants will be invited for furthers process. (JobsCDC.com / Source)

Notes :

JobsCDC.com now available on android device. Download now on Google Play here. Please be aware of recruitment fraud. The entire stage of this selection process is free of charge. PT Kimia Farma (Persero) Tbk - D3, S1, S2 PMMB Internship Program Kimia Farma July 2019 will never ask for fees or upfront payments for any purposes during the recruitment process such as transportation and accommodation.

Advertisements

Related Jobs :